Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2009 May 11.

Published in final edited form as: Arthritis Rheum. 2008 Dec;58(12):3924–3931. doi: 10.1002/art.24137

Serum concentrations of a) S100A12 and b) CRP in patients with SJIA, FMF, systemic infections, NOMID, MWS, ALL, AML, and in a group of healthy controls. Box plots show the median (horizontal line), mean (bold horizontal line), and the 25th and 75th percentiles. Bars show the 10th and 90th percentiles. There was no significant difference for S100A12 between active SJIA and FMF but between SJIA and the other disorders and healthy controls. CRP levels between SJIA and systemic infections did not differ significantly; healthy controls had CRP levels lower than 5mg/l. (*p<0.05, **p<0.01, ***p<0.001 versus SJIA).

Serum concentrations of a) S100A12 and b) CRP in patients with SJIA, FMF, systemic infections, NOMID, MWS, ALL, AML, and in a group of healthy controls. Box plots show the median (horizontal line), mean (bold horizontal line), and the 25th and 75th percentiles. Bars show the 10th and 90th percentiles. There was no significant difference for S100A12 between active SJIA and FMF but between SJIA and the other disorders and healthy controls. CRP levels between SJIA and systemic infections did not differ significantly; healthy controls had CRP levels lower than 5mg/l. (*p<0.05, **p<0.01, ***p<0.001 versus SJIA).